174 related articles for article (PubMed ID: 23945459)
1. Antipsychotics for primary alcohol dependence: a systematic review and meta-analysis of placebo-controlled trials.
Kishi T; Sevy S; Chekuri R; Correll CU
J Clin Psychiatry; 2013 Jul; 74(7):e642-54. PubMed ID: 23945459
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials.
Kishi T; Matsuda Y; Iwata N; Correll CU
J Clin Psychiatry; 2013 Dec; 74(12):e1169-80. PubMed ID: 24434105
[TBL] [Abstract][Full Text] [Related]
3. Are antipsychotics effective for the treatment of anorexia nervosa? Results from a systematic review and meta-analysis.
Kishi T; Kafantaris V; Sunday S; Sheridan EM; Correll CU
J Clin Psychiatry; 2012 Jun; 73(6):e757-66. PubMed ID: 22795216
[TBL] [Abstract][Full Text] [Related]
4. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
Krzystanek M; Krupka-Matuszczyk I
Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
[TBL] [Abstract][Full Text] [Related]
5. Antipsychotic medications for the treatment of delirium: a systematic review and meta-analysis of randomised controlled trials.
Kishi T; Hirota T; Matsunaga S; Iwata N
J Neurol Neurosurg Psychiatry; 2016 Jul; 87(7):767-74. PubMed ID: 26341326
[TBL] [Abstract][Full Text] [Related]
6. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
[TBL] [Abstract][Full Text] [Related]
7. Atypical antipsychotics for psychosis in adolescents.
Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
[TBL] [Abstract][Full Text] [Related]
8. Aripiprazole for the management of schizophrenia in the Japanese population: a systematic review and meta-analysis of randomized controlled trials.
Kishi T; Matsuda Y; Matsunaga S; Iwata N
Neuropsychiatr Dis Treat; 2015; 11():419-34. PubMed ID: 25759585
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of adjunctive topiramate for schizophrenia: a meta-analysis of randomized controlled trials.
Zheng W; Xiang YT; Xiang YQ; Li XB; Ungvari GS; Chiu HF; Correll CU
Acta Psychiatr Scand; 2016 Nov; 134(5):385-398. PubMed ID: 27585549
[TBL] [Abstract][Full Text] [Related]
10. Are antipsychotics or antidepressants needed for psychotic depression? A systematic review and meta-analysis of trials comparing antidepressant or antipsychotic monotherapy with combination treatment.
Farahani A; Correll CU
J Clin Psychiatry; 2012 Apr; 73(4):486-96. PubMed ID: 22579147
[TBL] [Abstract][Full Text] [Related]
11. Association With Hospitalization and All-Cause Discontinuation Among Patients With Schizophrenia on Clozapine vs Other Oral Second-Generation Antipsychotics: A Systematic Review and Meta-analysis of Cohort Studies.
Masuda T; Misawa F; Takase M; Kane JM; Correll CU
JAMA Psychiatry; 2019 Oct; 76(10):1052-1062. PubMed ID: 31365048
[TBL] [Abstract][Full Text] [Related]
12. A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholism.
Kampman KM; Pettinati HM; Lynch KG; Whittingham T; Macfadden W; Dackis C; Tirado C; Oslin DW; Sparkman T; O'Brien CP
J Clin Psychopharmacol; 2007 Aug; 27(4):344-51. PubMed ID: 17632217
[TBL] [Abstract][Full Text] [Related]
13. Efficacy for Psychopathology and Body Weight and Safety of Topiramate-Antipsychotic Cotreatment in Patients With Schizophrenia Spectrum Disorders: Results From a Meta-Analysis of Randomized Controlled Trials.
Correll CU; Maayan L; Kane J; Hert MD; Cohen D
J Clin Psychiatry; 2016 Jun; 77(6):e746-56. PubMed ID: 27337425
[TBL] [Abstract][Full Text] [Related]
14. A randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependence.
Anton RF; Kranzler H; Breder C; Marcus RN; Carson WH; Han J
J Clin Psychopharmacol; 2008 Feb; 28(1):5-12. PubMed ID: 18204334
[TBL] [Abstract][Full Text] [Related]
15. Blonanserin for schizophrenia: systematic review and meta-analysis of double-blind, randomized, controlled trials.
Kishi T; Matsuda Y; Nakamura H; Iwata N
J Psychiatr Res; 2013 Feb; 47(2):149-54. PubMed ID: 23131856
[TBL] [Abstract][Full Text] [Related]
16. Risks and Benefits of Nalmefene in the Treatment of Adult Alcohol Dependence: A Systematic Literature Review and Meta-Analysis of Published and Unpublished Double-Blind Randomized Controlled Trials.
Palpacuer C; Laviolle B; Boussageon R; Reymann JM; Bellissant E; Naudet F
PLoS Med; 2015 Dec; 12(12):e1001924. PubMed ID: 26694529
[TBL] [Abstract][Full Text] [Related]
17. NMDA receptor antagonists interventions in schizophrenia: Meta-analysis of randomized, placebo-controlled trials.
Kishi T; Iwata N
J Psychiatr Res; 2013 Sep; 47(9):1143-9. PubMed ID: 23692933
[TBL] [Abstract][Full Text] [Related]
18. The Impact of Varenicline on Alcohol Consumption in Subjects With Alcohol Use Disorders: Systematic Review and Meta-Analyses.
Gandhi KD; Mansukhani MP; Karpyak VM; Schneekloth TD; Wang Z; Kolla BP
J Clin Psychiatry; 2020 Feb; 81(2):. PubMed ID: 32097546
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of aripiprazole once monthly for schizophrenia: a systematic review and meta-analysis of randomized controlled trials.
Oya K; Kishi T; Iwata N
Neuropsychiatr Dis Treat; 2015; 11():2299-307. PubMed ID: 26366084
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
